Users Discontinuing Slimming Medications Regain Pounds Far More Rapidly Than People Using Diet and Exercise

Fresh analysis suggests that patients who stop using blockbuster slimming jabs like Wegovy and Mounjaro can put back on shed pounds far faster than those who end traditional lifestyle plans.

Research printed in a prominent medical journal demonstrates that while obese individuals frequently drop about a fifth of their total mass while using the jabs, the mass comes back at an average rate of nearly a kilo each month after stopping.

"People purchasing such medications must be aware of the risk of fast weight regain when the treatment ends," cautioned expert Dr. Susan Jebb.

That rate of recovery implies a reversion to original weight within about one and a half years.

Analyzing Therapies

The study, which examined 37 of trials involving thousands of patients, compared the results of GLP-1 agonists with older methods.

Scientists emphasize that people who lose weight through dieting usually see a less rapid weight regain—around 0.1 kg a month—after stopping.

Understanding the Quick Rebound

Experts propose the way of the jabs explains the amplified rebound.

GLP-1 drugs copy a natural hormone called GLP-1, which moderates appetite.

"Artificially providing the hormone levels several times higher than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication results in appetite is unsuppressed, making binge eating much more probable."

A Lifelong Condition?

Medical guidelines advise the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.

Many experts contend that, due to the significant potential of relapse, the therapy might need to be ongoing.

This perspective is supported by drug manufacturers, who note that the findings "highlight the long-term character of excess weight," comparing it to managing conditions like diabetes.

User Experiences

People who have come off the medication report a intense resurgence of appetite.

"It felt as if a switch that goes on and I was suddenly starving," described one woman.

The struggle is compounded if patients have not developed lasting dietary or behavioural modifications during therapy.

Widespread Adoption

Figures indicate that a significant number of adults in the UK have used these injections in the last 12 months, with interest continuing to grow.

• Use is more common among females than men.
• The middle-aged age group shows the highest usage rates.
• A large proportion obtain the drugs through private healthcare rather than public health services.

Ultimately, researchers stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic solution and lasting health benefits relies on ongoing behavioural management.